Vigency of metabolic syndrome;Vigencia del síndrome metabólico

Acta Bioquimica Clinica Latinoamericana

Volumn 45, Issue 3, 2011, Pages 423-430

  García, Edgar Acosta ^a  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

Author keywords

Adults; Children; Diabetes; Metabolic syndrome; Obesity

Indexed keywords

EID: 84856626887     PISSN: 03252957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (55)

1. Bays H, González J, Bray G, Kitabchi A, Bergman D, Schorr A, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6(3):343-68.
2. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva 1998.
3. López-Blanco M, Carmona A. La transición alimentaria nutricional: Un reto en el siglo XXI. An Venez Nutr 2005;18(1):90-104.
4. Pedroso E, Castillo M, Bonneaou G, Ibáñez M, Castro C, Jiménez S, et al. Síndrome metabólico y factores de riesgo asociados con el estilo de vida de adolescentes de una ciudad de Argentina, 2005. Pam Am J Public Health 2008;24(3):140-60.
5. Izaguirre-Espinoza I, López-Contreras Blanco M, Macias-Tomei C. Estimación a edad de la menarquia en un estudio longitudinal: comparación de métodos. Acta Cient Ven 1989;40:215-21.
6. Macias-Tomei C, Landaeta-Jiménez M, Bosch V, Méndez CA. Perfil antropométrico, bioquímico y de presión arterial en escolares obesos de Caracas, según estrato social. Arch Venez Puer Ped 2002;65(2):50-61.
7. Hirschler V, Aranda C, Oneto A, González C. ¿Es la acantosis nigricans un signo de insulinorresistencia en adolescentes obesos? Arch Argent Pediatr 2004;102:115-20.
8. Schnell M, Domínguez Z, Carrera C. Aspectos genéticos, clínicos y fisiopatológicos del Síndrome Metabólico. An Venez Nutr 2007;20(2):92-8. (Pubitemid 351761406)
9. a. ed. Washington DC: Organización Panamericana de la Salud; 2000. p. 27-32.
10. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37(12):1595-607. (Pubitemid 19004941)
11. Third Report of the Nacional Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report. Bethesda, Md: National Heart, Lung, and Blood Institute. Circulation 2002;106(25):3143-421.
12. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628-47.
13. Chacín L, Chacín N, Chapín J. Vigencia del síndrome metabólico. Diabetes Int 2009;1(4):86-98.
14. Caprio S. Definitions and pathophisiology of the metabolic syndrome in obese children and adolescents. Int J Obes 2005;29(2):24-5.
15. Bays HE, Chapman RH, Grande S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007;61(5):737-47. (Pubitemid 46587875)
16. Doelle G. The clinical picture of metabolic syndrome. An Update on this complex of conditions and risk factors. Posgrad Med 2004;116:30-8. (Pubitemid 38886681)
17. Macias-Tomei C. Síndrome metabólico en niños y adolescentes. Arch Venez Puer Ped 2009;72(1):30-7.
18. Aguilera MA, Gil M, Cañate R, Gil A. Alteraciones del metabolismo lipídico en la obesidad. Rev Esp Obes 2006;4(5):261-74.
19. Raz I, Eldor R, Cernea S, Shafrir E. Diabetes: insulin resistence and derangements in lipid metabolism. Cure Through intervention in fat transport and storage. Diabetes Med Res Rev 2005;21(1):3-14.
20. Lozada M, Machado S, Manrique M, Martínez D, Suárez D, Guevara H. Factores de riesgo asociados al síndrome metabólico en adolescentes. Gac Méd Caracas 2008;116(4):323-9.
21. Hirschler V, Calcagno ML, Aranda C, Maccallini G, Jadzinsky M. Síndrome metabólico en la infancia y su asociación con insulinorresistencia. Arc Argent Pediatr 2006;104(6):486-91.
22. Cersosimo E, Defronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006;96:47-64.
23. Brandão A, Magalhães M, Pozzan R, Brandão A. Síndrome metabólico en jóvenes: diagnóstico y tratamiento. Rev Esp Cardiol 2005;58(2):3-13.
24. Update on Task Force Report on High Blood Pressure in Children and Adolescents. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A Working Group Report from the National High Blood Pressure Education Program. Pediatrics 1996;98:649-58.
25. Pajuelo J, Pando R, Leyva M, Hernández K, Infantes R. Resistencia a la insulina en adolescentes con sobrepeso y obesidad. An Fac Med Lima 2006;67(1):23-9.
26. Reaven G. The metabolic syndrome on the insulin resistente syndrome? Different names, different concepts, and different goal. Endocrinol Metab Clin North Am 2004;33:283-303. (Pubitemid 38680631)
27. Bastarrachea R, Curran J, Bolado V, Kent J, López J, Téllez J, et al. Vinculando la respuesta inflamatoria, la obesidad y la diabetes con la sobrecarga (estrés) del retículo endoplásmico a través de las acciones de la selenoproteína S. Rev Endocrinol Nutr 2006;14(2):89-101.
28. Assy N, Nassar F, Nasser G, Grosovski M. Olive in consumption and non-alcoholic fatty liver disease. World J Gastroenterol 2009;15(15):1809-15.
29. Hayden MR. Global risk reduction of reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy. Med Hypot Res 2004 1:171-85.
30. Díaz M, Baiza L, Ibáñez MA, Pascoe D, Guzmán A, Kumate J. Aspectos moleculares del daño tisular inducido por la hiperglucemia crónica. Gac Méd Mex 2004;140:437-47.
31. Renna N, Vázquez M, González S, Lama C, Cruzado M, Miatello R. Vascular expresión of proinflammatory transcription factors in a model of metabolic syndrome. Rev Argent Cadiol 2007;75(1):37-41.
32. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. Movin an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007;49(21):2129-38. (Pubitemid 46783865)
33. Everett BM, Kurt T, Buring JE, Ridker PM. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006;48:2235-42. (Pubitemid 44855447)
34. Cao JJ, Thach C, Manolio TA. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Ciculation 2003;108:166-70. (Pubitemid 36871298)
35. Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002;22(1):173-8. (Pubitemid 34076250)
36. Valenzuela A. Tejido adiposo: algo más que grasa corporal. Rev Esp Obes 2004;2:327-50.
37. WHO consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. WHO/NCD/NCS/99. 2; 31-3.
38. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndromea new worldwide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469-80.
39. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28. (Pubitemid 40523737)
40. Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y. Appropiate BMI for Asian populations. Lancet 2004;363:157-63.
41. Zimmet G, Alberti KG, Serrano M. Una definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: Fundamentos y resultados. Rev Esp Cardiol 2005:1371-6. (Pubitemid 43193350)
42. Khan R, Buse J, Ferranini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2005;28:2289-304. (Pubitemid 41242486)
43. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931-8. (Pubitemid 40740871)
44. Posadas C. Obesidad y el síndrome metabólico en niños y adolescentes. Rev Endocrinol Nutr 2005;13(3):45-6.
45. Cook S, Weitzman M, Auinger P. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7. (Pubitemid 36988016)
46. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents. Findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-7. (Pubitemid 39407358)
47. Weiss R, Dziura J, Burger TS. Obesity and the metabolic syndrome in children and adolescents. N Engl Med 2004;350:2362-74. (Pubitemid 38702847)
48. Viner RM, Segal TY, Lichtarowicz K, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005;90:10-4. (Pubitemid 40052245)
49. Seo SJ, Lee HY, Lee SW. The prevalence of the metabolic syndrome in korean children and adolescentes: Comparation of the criteria of Cook et al., Cruz and Goran, and Ferranti et al. Yonsei Med J 2008;49(4):563-72.
50. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep 2004;4:53-62. (Pubitemid 39359511)
51. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
52. Rodríguez M, Salazar B, Violante R, Guerrero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care 2004;27:2516-7. (Pubitemid 39281417)
53. Paoli M, Pereira A. Síndrome metabólico en el niño y adolescente. Rev Med Venez Endocrinol Metab 2006;4(1):3-14.
54. Zimmet P, Alberti K, Kaufman F, Tajima N, Silink M, Arslanian S, et al. IDF Consensus Group. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007;8:299-306. (Pubitemid 47422902)
55. Ryder E. Una epidemia global: El síndrome metabólico. An Venez Nutr 2005;18(1):105-9.